Bio-Techne (TECH) Net Cash Flow (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.63% |
| Dec 31, 2025 | 271.75% |
| Sep 30, 2025 | -296.37% |
| Jun 30, 2025 | 122.78% |
| Mar 31, 2025 | -691.47% |
| Dec 31, 2024 | -114.76% |
| Sep 30, 2024 | 364.64% |
| Jun 30, 2024 | -45.64% |
| Mar 31, 2024 | 155.25% |
| Dec 31, 2023 | 5.43% |
| Sep 30, 2023 | -142.66% |
| Jun 30, 2023 | 236.99% |
| Mar 31, 2023 | -401.54% |
| Dec 31, 2022 | -272.66% |
| Sep 30, 2022 | -75.10% |
| Jun 30, 2022 | 139.25% |
| Mar 31, 2022 | -476.98% |
| Dec 31, 2021 | 663.74% |
| Sep 30, 2021 | -87.27% |
| Jun 30, 2021 | -35.22% |
| Mar 31, 2021 | 309.99% |
| Dec 31, 2020 | -141.04% |
| Sep 30, 2020 | 320.52% |
| Jun 30, 2020 | -120.38% |
| Mar 31, 2020 | 663.40% |
| Dec 31, 2019 | 464.22% |
| Sep 30, 2019 | -79.33% |
| Jun 30, 2019 | -27.27% |
| Mar 31, 2019 | 195.23% |
| Dec 31, 2018 | 68.32% |
| Sep 30, 2018 | -165.38% |
| Jun 30, 2018 | 207.37% |
| Mar 31, 2018 | -176.95% |
| Dec 31, 2017 | 359.27% |
| Sep 30, 2017 | -163.26% |
| Jun 30, 2017 | 5,753.57% |
| Mar 31, 2017 | 105.57% |
| Dec 31, 2016 | -1,731.95% |
| Sep 30, 2016 | -20.40% |
| Jun 30, 2016 | -80.75% |
| Mar 31, 2016 | -82.25% |
| Dec 31, 2015 | 277.68% |
| Sep 30, 2015 | 78.80% |
| Jun 30, 2015 | -425.11% |
| Mar 31, 2015 | 993.98% |
| Dec 31, 2014 | 99.14% |
| Sep 30, 2014 | -211.86% |
| Jun 30, 2014 | 676.22% |
| Mar 31, 2014 | 83.98% |
| Dec 31, 2013 | 116.44% |
| Sep 30, 2013 | -752.09% |
| Jun 30, 2013 | 20.97% |
| Mar 31, 2013 | -12.83% |
| Dec 31, 2012 | -4.80% |
| Sep 30, 2012 | -43.86% |
| Jun 30, 2012 | 67.26% |
| Mar 31, 2012 | 514.95% |
| Dec 31, 2011 | -10.14% |
| Sep 30, 2011 | 102.94% |
| Jun 30, 2011 | -518.14% |
| Mar 31, 2011 | -10.68% |
| Dec 31, 2010 | 26.85% |
| Sep 30, 2010 | 241.92% |
| Jun 30, 2010 | 84.25% |
| Mar 31, 2010 | -493.96% |
| Dec 31, 2009 | 19.43% |